In Event-Driven Strategy Hedge Funds, M&A is the Headliner
Hedge fund firms using event-driven strategies are feasting on what has been among the heaviest periods in years of corporate chomping.
David Turner
May 13, 2014
The Pfizer Inc. company logo is seen on packaging for Neurontin tablets, produced by Pfizer Inc., in this arranged photograph taken in London, U.K., on Friday, May 2, 2014. AstraZeneca Plc rejected Pfizer Inc.'s sweetened takeover proposal, saying the 63.1 billion-pound ($106.5 billion) offer fails to recognize the value of the promising experimental medicines under development by the U.K.'s second-biggest drugmaker. Photographer: Chris Ratcliffe/Bloomberg
Chris Ratcliffe/Bloomberg
